Sunday, May 15, 2016
9:00 a.m. - 11:00 a.m. |
| A21 |
Chronic Airway Inflammation: Microbial Influence |
| A22 |
Technology for Disease Identification and Management in Pulmonary and Critical Care |
| A23 |
Understanding and Reducing COPD Rehospitalizations |
| A24 |
Autoimmune Interstitial Lung Disease |
| A25 |
Critical Care: Functional Outcomes in ICU Survivors |
| A26 |
Smoke, Pollutants, and Toxins: Insights from Bench Studies |
| A27 |
Advances in Pediatric Sleep |
| A28 |
From PE to CTEPH: Fade Away or Not? |
| A29 |
Inflammation and Mechanisms of Airway Smooth Muscle Contraction |
| A30 |
Advances in Lung Cancer Screening and Pulmonary Nodule Assessment |
Sunday, May 15, 2016
2:15 p.m. - 4:15 p.m. |
| A101 |
Host Defense, Lung Injury, and Fibrosis: Innate Mechanisms |
| A102 |
Highlights in Patient-Centered Research: Methods and Outcomes |
| A103 |
IPF: More about Therapy and Outcomes |
| A104 |
Critical Care: Sepsis Translational Insights |
| A105 |
Critical Care: Variability in Care, Opportunities for Adoption of Deadoption |
| A106 |
Epidemiology and Risk Factors of Asthma: From the Crib to Adulthood |
| A107 |
Etiology of PAH: Go your own Way |
| A108 |
Micro RNAs, RNA SEQ, LNCRNA: Biology and Function |
| A109 |
Remodeling and the Matrix |
| A110 |
The Sleepy and Aging Brain: OSA and Cogniion in the Elderly |
Monday, May 16, 2016
9:00 a.m. - 11:00 a.m. |
| B21 |
Genetics, Genomics, and Gene Expression in Asthma and COPD |
| B22 |
Burden of Pulmonary and Critical Care Medicine: Cost and Utilization |
| B23 |
Cardiovascular and Respiratory Ineractions in COPD |
| B24 |
Occupational Medicine |
| B25 |
Non-Tuberculous Mycobacteria: Epidemiology, Diagnosis and Treatment |
| B26 |
Updates in Pediatric Lung Infections |
| B27 |
Hypoxia and the Pulmonary Vasculature: Breathless in San Francisco |
| B28 |
Advances in Stem Cells in Injury and Repair for 2016 |
| B29 |
The State of Unrest: Sleep/SDB in the ICU and Hospital |
| B30 |
Molecular and Immunological Aspects of Lung Cancer |
Monday, May 16, 2016
2:15 p.m. - 4:15 p.m. |
| B101 |
Phenotyping of Asthma in the Era of Biomarkers and Omics |
| B102 |
Strategies to Improve Care Quality in Pulmonary and Critical Illness |
| B103 |
Advances in Diagnostic Bronchoscopy |
| B104 |
Respiratory Failure: Lung Regional and Translational Mechanisms in ARDS |
| B105 |
COPD: Epidemiology and Genetics |
| B106 |
Cellular/Molecular Mechanisms and Translaional Aspects of Respiratory Tract Infections |
| B107 |
Tuberculosis: Issues During Treatment |
| B108 |
Advances in Pediatric Lung Funcion Testing |
| B109 |
Highlights and Advances in Pulmonary Rehabilitation |
| B110 |
Novel Therapies and Targets in Fibrosis |
Tuesday, May 17, 2016
9:00 a.m. - 11:00 a.m. |
| C21 |
Applying Omics Technologies to Reveal Gene Regulators and Biomarkers in Lung Development and Disease |
| C22 |
Airway Epithelium: Molecular Regulation of Inflammation |
| C23 |
Contemporary Questions in Lung Transplantation |
| C24 |
Critical CAre: Can ICU Design Improve ICU Care? |
| C25 |
HIV-Associated Lung Infections/Disorders-From Basic to Clinical |
| C26 |
Family Centered Critical Care Within and Beyond the ICU |
| C27 |
News from the NICU and PICU |
| C28 |
The Ties that Bind: Basic Studies in ALI and Barrier Function |
| C29 |
Protectors of the Lung: Innate Immune Responses in Acute Lung Injury |
| C30 |
Acute Lung Injury: Cell Function, Signaling and Stretch |
Tuesday, May 17, 2016
2:15 p.m. - 4:15 p.m. |
| C101 |
Sarcoidosis |
| C102 |
Strategies to Understand ILD: Registries, Prognostic Indicators and More |
| C103 |
Eosinophils in COPD and the Asthma-COPD Overlap Syndrome: Sorting Through the Chaos of ACOS |
| C104 |
Rare Interstitial Lung Disease: LAM, Cystic Lung Disease, and More |
| C105 |
Respiratory Failure: Mechanistic Insights from Lung Injury Models |
| C106 |
Wrecking Ball: New Paradigms in Understanding and Treatment of PH |
| C107 |
Immunity, Exacerbation and Immune Cell Function in COPD |
| C108 |
Advances in Lung Function Assessment |
| C109 |
Pathogenesis of SDB: Does it Matter? |
| C110 |
Mesothelioma and Malignant Pleural Disease: From Bench to Bedside to Community |
Wednesday, May 18, 2016
9:00 a.m. - 11:00 a.m. |
| D21 |
Asthma Treatment: Glucocorticoids, Biologicals and Beyond |
| D22 |
Reducing Harms of Tobacco Use |
| D23 |
Symptoms Matter: Cough, Dyspnea, Fatigue and Quality of Life |
| D24 |
Gram Negative Pneumonias: From Bench to Bedside |
| D25 |
Neonatal and Congenital Lung Diseases |
| D26 |
I'm on Fire - Inflammation in Pulmonary Vascular Disease |
| D27 |
Macrophages: Resolvers, Responders or Both? |
| D28 |
Novel Imaging Methods to Study Lung Disease |
| D29 |
Bench to Bedside: Translational Science in SDB |
| D30 |
Novel Clinical Approaches to Thoracic Malignancies |
Wednesday, May 18, 2016
2:15 p.m. - 4:15 p.m. |
| 101 |
Allergies and Asthma: Novel Regulatory Pathways |
| D102 |
Figuring Out What We Don't Know: Advances in Medical Education |
| D103 |
Critical Care: Improving Palliative and End of Life Care in the ICU |
| D104 |
Critical Care: Pre-ICU, Rapid Response, and Initial Treatment for Sepsis |
| D105 |
Respiratory Failure: Role of the Diaphragm and Skeletal Muscles |
| D106 |
Biomass Smoke, Vog, and Pollutants |
| D107 |
Tuberculosis Infection and Disease: Epidemiology and Diagnosis |
| D108 |
Pediatric Cases: A Room Full of Zebras |
| D109 |
What's Hiding Under the Covers: Basic Science in SDB |
| D110 |
Unusual Tumors of the Chest |
